Wealth Enhancement Advisory Services’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.27M	Buy	75,708 +7,172	+10%	+$368K	﹤0.01%	1351
2026 Q2	$3.64M	Buy	+68,536	New	+$3.06M	0.01%	1203

Other funds holding BBC

Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Wealth Enhancement Advisory Services's BBC Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Virtus Biotech Clinical Trials ETF (BBC) stake by 10% in Q3 2026, buying an estimated $368K and bringing the position to 75,708 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Wealth Enhancement Advisory Services first reported a position in BBC in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.64M in Q2 2026. 3 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

Wealth Enhancement Advisory Services held 75,708 shares of Virtus Biotech Clinical Trials ETF worth $3.27M as of Q3 2026.
Wealth Enhancement Advisory Services bought 7,172 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $368K.
Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #1351 holding.
Wealth Enhancement Advisory Services first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2026 and has held it in 2 quarters since.
Wealth Enhancement Advisory Services's Virtus Biotech Clinical Trials ETF position peaked at $3.64M in Q2 2026.
3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.